VivoSim Labs (VIVS) Operating Margin (2011 - 2026)
VivoSim Labs (VIVS) posted quarterly Operating Margin of 7967.5% for Q1 2026, down 178319.0% year-over-year from N/an in Q1 2025, and up 24.67% quarter-over-quarter from 10576.92% in Q4 2025.
VivoSim Labs (VIVS) Operating Margin (2011 - 2026) Analysis & Trends
VivoSim Labs' Operating Margin history runs 14 years deep, the most recent figure standing at 7967.5% for Q1 2026.
- In Q1 2026, Operating Margin fell 178319.0% year-over-year to 7967.5%; the TTM figure through Mar 2026 stood at 8768.7% (down 759.0% YoY), while the FY2026 annual figure was 8768.7%, down 759.0% from the prior year.
- Operating Margin for Q1 2026 stood at 7967.5%, up from 10576.92% in the prior quarter.
- The five-year high for Operating Margin was 127.53% in Q1 2022, with the low at 73600.0% in Q4 2023.
- The 5-year median for Operating Margin is 7967.5% (2026), against an average of 11704.12%.
- The sharpest annual moves came in 2023 and 2024: Operating Margin plunged 7103588 bps in 2023, then surged 5915000 bps in 2024.
- VivoSim Labs' Operating Margin stood at 2564.12% in 2022, then sank by 2770 bps to 73600.0% in 2023, then jumped by 80 bps to 14450.0% in 2024, then advanced by 27 bps to 10576.92% in 2025, then grew by 25 bps to 7967.5% in 2026.
- Business Quant data shows VIVS's Operating Margin at 7967.5% in Q1 2026, 10576.92% in Q4 2025, and 9410.71% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 37.40% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 30.15% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 32.54% |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -562.07% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 19.06% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 17.93% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -0.36% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 19.75% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -35.57% |
| 10 | VivoSim Labs | 1.46 Mn | 1.46 Mn | - | -15,327.78% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -15,327.78% |
| Mar 31, 2026 | -7,967.50% |
| Dec 31, 2025 | -10,576.92% |
| Sep 30, 2025 | -9,410.71% |
| Jun 30, 2025 | -7,878.38% |
| Mar 31, 2025 | -6,184.31% |
| Dec 31, 2024 | -14,450.00% |
| Sep 30, 2024 | -8,693.33% |
| Jun 30, 2024 | -8,682.05% |
| Mar 31, 2024 | -10,675.86% |
| Dec 31, 2023 | -73,600.00% |
| Jun 30, 2023 | -5,593.33% |
| Mar 31, 2023 | -4,801.85% |
| Dec 31, 2022 | -2,564.12% |
| Sep 30, 2022 | -4,355.84% |
| Mar 31, 2022 | -127.53% |
| Dec 31, 2019 | -1,756.38% |
| Sep 30, 2019 | -555.04% |
| Jun 30, 2019 | -976.20% |
| Mar 31, 2019 | -1,053.24% |